IL155509A0 - A combination comprising camptothecin and a stilbene derivative for the treatment of cancer - Google Patents

A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Info

Publication number
IL155509A0
IL155509A0 IL15550901A IL15550901A IL155509A0 IL 155509 A0 IL155509 A0 IL 155509A0 IL 15550901 A IL15550901 A IL 15550901A IL 15550901 A IL15550901 A IL 15550901A IL 155509 A0 IL155509 A0 IL 155509A0
Authority
IL
Israel
Prior art keywords
camptothecin
cancer
treatment
combination
stilbene derivative
Prior art date
Application number
IL15550901A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL155509A0 publication Critical patent/IL155509A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15550901A 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer IL155509A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24343100P 2000-10-27 2000-10-27
US24558200P 2000-11-06 2000-11-06
US25013800P 2000-12-01 2000-12-01
PCT/EP2001/012985 WO2002034244A2 (fr) 2000-10-27 2001-10-25 Combinaison de camptothecine et d'un derive de stilbene pour le traitement du cancer

Publications (1)

Publication Number Publication Date
IL155509A0 true IL155509A0 (en) 2003-11-23

Family

ID=27399663

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15550901A IL155509A0 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Country Status (22)

Country Link
US (1) US6562834B2 (fr)
EP (1) EP1333820A2 (fr)
JP (1) JP2004517821A (fr)
KR (1) KR100742524B1 (fr)
CN (1) CN1200712C (fr)
AU (2) AU2002216029B2 (fr)
BG (1) BG107806A (fr)
BR (1) BR0114856A (fr)
CA (1) CA2426898A1 (fr)
EA (1) EA005400B1 (fr)
EE (1) EE200300184A (fr)
HK (1) HK1058623A1 (fr)
HR (1) HRP20030382A2 (fr)
HU (1) HUP0302629A3 (fr)
IL (1) IL155509A0 (fr)
MX (1) MXPA03002882A (fr)
NO (1) NO324844B1 (fr)
NZ (1) NZ524855A (fr)
PL (1) PL365685A1 (fr)
SK (1) SK5122003A3 (fr)
WO (1) WO2002034244A2 (fr)
YU (1) YU29803A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
CA2383259A1 (fr) * 2002-04-23 2003-10-23 Celator Technologies Inc. Composes synergiques
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
TW200819409A (en) * 2006-10-19 2008-05-01 Univ Taipei Medical Z-stilbenes derivatives and the pharmaceutical composition thereof
CN105622431A (zh) 2011-01-28 2016-06-01 肯塔基大学研究基金会 茋类似物和治疗癌症的方法
CA2839451A1 (fr) 2011-06-27 2013-01-03 The Jackson Laboratory Procedes et compositions pour le traitement du cancer et d'une maladie auto-immune

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS57116015A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Antitumor agent
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS595188A (ja) 1982-06-30 1984-01-12 Yakult Honsha Co Ltd １０−ヒドロキシカンプトテシンの製造法
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (fr) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Derives de la campothecine et methode de preparation
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524804B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体及びその製造法
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
DE69209969T2 (de) 1991-10-29 1996-09-12 Glaxo Wellcome Inc Wasserlösliche Camptothecinderivate
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5670500A (en) 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5663177A (en) 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
AU716377B2 (en) 1995-06-21 2000-02-24 Ipsen Pharma S.A.S. New analogues of camptothecin, preparation processes, their use as medicaments and the pharmaceutical compositions containing them
JP3054669B2 (ja) 1995-10-16 2000-06-19 余川商事株式会社 積雪落下防止装置
JPH11296051A (ja) 1998-04-08 1999-10-29 Canon Inc プロセスカートリッジ
WO2000033888A2 (fr) * 1998-12-11 2000-06-15 Coulter Pharmaceutical, Inc. Composes de promedicaments et procede de preparation
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
WO2002056692A1 (fr) 2000-12-22 2002-07-25 Bristol-Myers Squibb Company Procedes relatifs a la modulation de la croissance tumorale et de la metastase

Also Published As

Publication number Publication date
NZ524855A (en) 2004-10-29
NO20031656L (no) 2003-04-10
CN1471396A (zh) 2004-01-28
HK1058623A1 (en) 2004-05-28
AU1602902A (en) 2002-05-06
CN1200712C (zh) 2005-05-11
CA2426898A1 (fr) 2002-05-02
HRP20030382A2 (en) 2005-04-30
NO324844B1 (no) 2007-12-17
KR100742524B1 (ko) 2007-08-02
MXPA03002882A (es) 2004-12-03
US20020115677A1 (en) 2002-08-22
YU29803A (sh) 2006-05-25
HUP0302629A3 (en) 2005-05-30
EA005400B1 (ru) 2005-02-24
JP2004517821A (ja) 2004-06-17
NO20031656D0 (no) 2003-04-10
PL365685A1 (en) 2005-01-10
BG107806A (bg) 2004-06-30
KR20030082544A (ko) 2003-10-22
EP1333820A2 (fr) 2003-08-13
BR0114856A (pt) 2004-06-15
SK5122003A3 (en) 2003-12-02
HUP0302629A2 (hu) 2003-11-28
EE200300184A (et) 2003-08-15
WO2002034244A3 (fr) 2003-05-30
WO2002034244A2 (fr) 2002-05-02
AU2002216029B2 (en) 2006-01-05
EA200300516A1 (ru) 2003-08-28
US6562834B2 (en) 2003-05-13

Similar Documents

Publication Publication Date Title
AU6147401A (en) Compositions and methods for the treatment of cancer
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
EP1311262A4 (fr) Traitement combine contre le cancer
EP1296697A4 (fr) Agents therapeutiques - i
GB0028429D0 (en) Therapy
HUP0300848A3 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
GB0001710D0 (en) Therapeutic treatment
AU1602902A (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
AU9402401A (en) Treatment of cancers
AU2096002A (en) Therapeutic treatment
GB0026015D0 (en) Cancer treatment
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
IL149281A0 (en) Treatment of cancer
GB0018887D0 (en) Compound and their therapeutic use
AU2001252235A1 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
AU6884801A (en) Therapeutic compounds and methods
GB0008161D0 (en) Treatment of cancer
GB0027780D0 (en) Treating cancer
GB0017620D0 (en) Flavonoids in cancer treatment
GB0018886D0 (en) Compounds and their therapeutic use
GB0018885D0 (en) Compounds and their therapeutic use
GB0018888D0 (en) Compounds and their therapeutic use
GB0014133D0 (en) Combination therapy
GB0014135D0 (en) Combination therapy
GB0013927D0 (en) Combination therapy